FBIO: Fortress Biotech Inc
FBIO exchange rate has changed by 0.00% for today. During the day, the instrument was traded at a low of 2.49 and at a high of 2.53.
Follow Fortress Biotech Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
FBIO News
- Prothena (PRTA) Reports Q3 Loss, Lags Revenue Estimates
- Ultragenyx (RARE) Reports Q3 Loss, Misses Revenue Estimates
- Apellis Pharmaceuticals, Inc. (APLS) Q3 Earnings and Revenues Top Estimates
- Fortress Biotech stock rises after subsidiary’s gout treatment enters Phase 3 trials
- Fortress Biotech stock plummets after FDA rejects Menkes disease drug
- Cal-Maine Foods Posts Downbeat Earnings, Joins Enanta Pharmaceuticals, AAR And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Cal-Maine Foods (NASDAQ:CALM), AAR (NYSE:AIR)
- Why Ryvyl Shares Are Trading Higher By 97%; Here Are 20 Stocks Moving Premarket - Senmiao Technology (NASDAQ:AIHS), AES (NYSE:AES)
- Why Docusign Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket - American Outdoor Brands (NASDAQ:AOUT), BrilliA (AMEX:BRIA)
- Fortress Biotech stock price target lowered to $17 at H.C. Wainwright
- Fortress Biotech (FBIO) Reports Q2 Loss, Beats Revenue Estimates
- Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates
- Coherus Oncology (CHRS) Reports Q2 Loss, Beats Revenue Estimates
- FDA grants orphan drug status to Mustang Bio’s glioma treatment
- Checkpoint Therapeutics shareholders approve Sun Pharma merger
- Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
- Fortress Biotech, Inc. (FBIO) Q4 2024 Earnings Call Transcript
- Checkpoint Agrees To Sun Pharma Buyout: This Deal Suits Both Parties (NASDAQ:CKPT)
- India’s Sun Pharma to buy Checkpoint Therapeutics for $355 mln
Frequently Asked Questions
What is FBIO stock price today?
Fortress Biotech Inc stock is priced at 2.52 today. It trades within 2.49 - 2.53, yesterday's close was 2.52, and trading volume reached 132. The live price chart of FBIO shows these updates.
Does Fortress Biotech Inc stock pay dividends?
Fortress Biotech Inc is currently valued at 2.52. Dividend policy depends on the company, while investors also watch 17.76% and USD. View the chart live to track FBIO movements.
How to buy FBIO stock?
You can buy Fortress Biotech Inc shares at the current price of 2.52. Orders are usually placed near 2.52 or 2.82, while 132 and 0.80% show market activity. Follow FBIO updates on the live chart today.
How to invest into FBIO stock?
Investing in Fortress Biotech Inc involves considering the yearly range 1.32 - 4.20 and current price 2.52. Many compare -0.79% and 31.94% before placing orders at 2.52 or 2.82. Explore the FBIO price chart live with daily changes.
What are Fortress Biotech, Inc. stock highest prices?
The highest price of Fortress Biotech, Inc. in the past year was 4.20. Within 1.32 - 4.20, the stock fluctuated notably, and comparing with 2.52 helps spot resistance levels. Track Fortress Biotech Inc performance using the live chart.
What are Fortress Biotech, Inc. stock lowest prices?
The lowest price of Fortress Biotech, Inc. (FBIO) over the year was 1.32. Comparing it with the current 2.52 and 1.32 - 4.20 shows potential long-term entry points. Watch FBIO moves on the chart live for more details.
When did FBIO stock split?
Fortress Biotech Inc has gone through stock splits historically. These changes are visible in , 2.52, and 17.76% after corporate actions.
- Previous Close
- 2.52
- Open
- 2.50
- Bid
- 2.52
- Ask
- 2.82
- Low
- 2.49
- High
- 2.53
- Volume
- 132
- Daily Change
- 0.00%
- Month Change
- -0.79%
- 6 Months Change
- 31.94%
- Year Change
- 17.76%
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- 50.3
- Fcst
- 55.3
- Prev
- 53.6
- Act
- 49.0
- Fcst
- 47.1
- Prev
- 50.3
- Act
- 4.7%
- Fcst
- 5.3%
- Prev
- 4.6%
- Act
- 3.6%
- Fcst
- 3.8%
- Prev
- 3.9%
- Act
- Fcst
- Prev
- 414
- Act
- Fcst
- Prev
- 546
- Act
- Fcst
- $11.78 B
- Prev
- $0.36 B
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev